Topiramate in the Prevention of Migraine Headache: Results from Two Randomized, Double-Blind, Placebo-Controlled Studies


Home \| About Dr. Robbins \| Archived Articles \| Headache Books \| Topic Index

Back to List

Title:

Author:
Date:
Source:

Topiramate in the Prevention of Migraine Headache:
Results from Two Randomized, Double-Blind,
Placebo-Controlled Studies
Matthew, N., et al
Posted July 2003
Presented at: 45th Annual Scientific Meeting
American Headache Society
June 19-22, 2003; Chicago, Illinois

Objectives: To assess the efficacy and safety of topiramate in the prevention of migraine headache.

Conclusions: In these studies, topiramate was associated with significant improvement in migraine at doses of 100 or 200 mg/day in each efficacy measure presented. The onset of efficacy was observed as early as the first month of treatment.

Home | About Dr. Robbins | Archived Articles | Headache Books | Topic Index